EcoDrugPlus

Atrial Natriuretic Peptide Receptor 1-Like

Ensembl ID : ENSDCDG00000026088
Gene Symbol: LOC114774165
3 Cross references
196 Possible Orthologues:

Atrial Natriuretic Peptide Receptor 1-Like

Ensembl ID : ENSDCDG00000016192
Gene Symbol: LOC114790746
2 Cross references
191 Possible Orthologues:

Aurora Kinase B

Ensembl ID : ENSDCDG00000026219
Gene Symbol: LOC114788590
3 Cross references
204 Possible Orthologues:

Aurora Kinase B-Like

Ensembl ID : ENSDCDG00000026218
Gene Symbol: LOC114788074
3 Cross references
204 Possible Orthologues:

Aurora Kinase C-Like

Ensembl ID : ENSDCDG00000034756
Gene Symbol: LOC114800572
3 Cross references
233 Possible Orthologues:

Beta-1 Adrenergic Receptor-Like

Ensembl ID : ENSDCDG00000004645
Gene Symbol: LOC114800042
3 Cross references
197 Possible Orthologues:

Beta-2 Adrenergic Receptor-Like

Ensembl ID : ENSDCDG00000033033
Gene Symbol: LOC114792907
3 Cross references
150 Possible Orthologues:

Beta-2 Adrenergic Receptor-Like

Ensembl ID : ENSDCDG00000022121
Gene Symbol: LOC114767937
3 Cross references
196 Possible Orthologues:

Beta-Parvin-Like

Ensembl ID : ENSDCDG00000027612
Gene Symbol: LOC114767167
3 Cross references
181 Possible Orthologues:

Beta-Secretase 1

Ensembl ID : ENSDCDG00000034153
Gene Symbol: BACE1
3 Cross references
221 Possible Orthologues:

Bradykinin Receptor B1

Ensembl ID : ENSDCDG00000013229
Gene Symbol: BDKRB1
1 Cross references
148 Possible Orthologues:

Bradykinin Receptor B2

Ensembl ID : ENSDCDG00000004233
Gene Symbol: BDKRB2
1 Cross references
159 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).